A Ceres researcher shows off seed samples in a laboratory at the Thousand Oaks-based company. Ceres Inc. has thrown a financial Hail Mary but it’s looking like a play even Aaron Rodgers can’t complete. The Thousand Oaks-based ag-biotech company held its third public offering in four years on Dec. 17. The offering, at 40 cents…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
